相关实验视频
Updated: Jul 12, 2025

08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
916
在老鼠中,trehalose通过增强AKT/TFEB通路依赖的自流延迟了绝经后的骨质疏松症
Yongli Wang1, Xingcun Li2, Hongliang Gao1
1Department of Orthopedics, Huzhou Central Hospital, Huzhou Basic and Clinical Translation of Orthopedics Key Laboratory, Huzhou, Zhejiang 313300, P.R. China.
Experimental and therapeutic medicine
|October 23, 2023
概括
作为一种自诱导剂的三糖在推迟老鼠绝经后骨质疏松症方面表现有前途. 这种效应可以通过增强Akt/TFEB通路依赖的自流来调节,从而提供潜在的治疗策略.
科学领域:
- 骨生物学和新陈代谢
- 细胞自细胞自
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症是老年人的主要健康问题,影响骨质和寿命.
- 自对于骨形成和维持身体平衡至关重要.
- 醇被确定为拉巴胺素 (mTOR) 独立自诱导物的机械性标.
研究的目的:
- 在大鼠模型中调查特雷糖在延迟绝经后骨质疏松症方面的潜力.
- 探索涉及自和Akt/TFEB通路的潜在机制.
主要方法:
- 建立了一个绝经后骨质疏松症大鼠模型.
- 使用血素和欧 (H&E) 染色用于组织学分析.
- 进行了西式涂抹,以评估蛋白质表达和通路激活.
- 使用微型计算机断层扫描 (CT) 扫描用于骨结构评估.
- 进行传输电子显微镜以可视化细胞自.
主要成果:
- 与模型组相比,Trehalose治疗改善了骨椎间板组织结构.
- 微型CT扫描显示,在三糖组中,骨轨道膜成像能力较强.
- 西方涂抹和电子显微镜证实在三糖组中增强了自和自流.
- 有证据表明,Akt/TFEB通路被三糖激活.
结论:
- 特雷霍洛斯在推迟老鼠绝经后骨质疏松症方面表现出有效性.
- 通过诱导和增强Akt/TFEB通路依赖的自性来潜在地实现治疗效果.
- 含有三醇的药物是治疗绝经后骨质疏松症的一个有希望的途径.
更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K

